MedPath

A randomised controlled trial investigating the efficacy of Eleutherococcus senticisus (Araliacae: Siberian ginseng) on the amelioration of the symptoms of overtraining syndrome in Ironman triathletes

Not Applicable
Conditions
Overtraining syndrome
Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
Alternative and Complementary Medicine - Herbal remedies
Registration Number
ACTRN12611000776909
Lead Sponsor
Murdoch University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
66
Inclusion Criteria

Athletes entered in an Ironman triathlon

Exclusion Criteria

Medically diagnosed conditions, medically diagnosed cognitive impairment, participants currently on prescribed medication for any condition except the oral birth control pill

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o decrease in performance times in the Ironman event. A performance decrement of 10% or greater of elapsed time in the Ironman event which cannot be explained by any other means (wind, waves, cureents, punctures, injuries) is regarded as overtraining syndrome.[12 weeks];Performance decrease in time trials. These time trial consist of a 400m swim in a 50m heated outdoor pool, a 4 km run held on an enclosed, but open roofed running track, and a 20 km simulated time trial on a cycle ergometer using the Tacx System[0 weeks, 6 weeks and 12 weeks];Changes in blood concentrations of corticotrophic releasing hormone (CRH), adrenocorticitrophic releasing hormone (ACTH) and cortisol[0 weeks, 6 weeks, 12 weeks]
Secondary Outcome Measures
NameTimeMethod
o jump in day to day waking pulse of 5 beats per minute or more. Pulse is taken manually by the participant and counted for one full minute[The pulse is taken daily and any jump in waking heart rate from one day to the next of 5 beats per minute or more is regarded as indicative of overtraining syndrome. The pulse rate is therefore assessed over the entire 12 week period];Daily waking rectal temperature is taken and monitored. Temperature is taken by an Omron electronic digital thermometer. No mercury is involved[Daily for 12 weeks. Changes in core temperature is taken as evidence that the hypothalamic control of core temperature has been altered];Any changes in blood concentration of CRH, ACTH and cortisol will be correlated to performce decrements[0 weeks, 6 weeks, 12 weeks]
© Copyright 2025. All Rights Reserved by MedPath